Literature DB >> 25154828

Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis.

Rafael F Duarte1, Ariane Boumendil2, Francesco Onida3, Ian Gabriel4, Reyes Arranz5, William Arcese6, Xavier Poiré7, Guido Kobbe8, Franco Narni9, Agostino Cortelezzi3, Eduardo Olavarría10, Norbert Schmitz11, Anna Sureda12, Peter Dreger13.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25154828     DOI： 10.1200/JCO.2014.57.5597

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  20 in total

Review 1.  Mature T-cell leukemias: Molecular and Clinical Aspects.

Authors:  Nathanael G Bailey; Kojo S J Elenitoba-Johnson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 2.  [Role of stem cell transplantation in treatment of primary cutaneous T‑cell lymphoma].

Authors:  R Stranzenbach; S Theurich; M Schlaak
Journal:  Hautarzt       Date:  2017-09       Impact factor: 0.751

Review 3.  Is It Time to Revisit the Role of Allogeneic Transplantation in Lymphoma?

Authors:  Satish Shanbhag; Nina Wagner-Johnston; Richard F Ambinder; Richard J Jones
Journal:  Curr Oncol Rep       Date:  2019-06-10       Impact factor: 5.075

Review 4.  Mycosis Fungoides and Sézary Syndrome: An Update.

Authors:  Cecilia Larocca; Thomas Kupper
Journal:  Hematol Oncol Clin North Am       Date:  2019-02       Impact factor: 3.722

5.  Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS).

Authors:  Erden Atilla; Pinar Ataca Atilla; Sinem Civriz Bozdag; Meltem Kurt Yuksel; Selami Kocak Toprak; Pervin Topcuoglu; Bengu Nisa Akay; Hatice Sanli; Gunhan Gurman; Muhit Ozcan
Journal:  Int J Hematol       Date:  2017-05-02       Impact factor: 2.490

Review 6.  Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.

Authors:  A Sureda; P Bader; S Cesaro; P Dreger; R F Duarte; C Dufour; J H F Falkenburg; D Farge-Bancel; A Gennery; N Kröger; F Lanza; J C Marsh; A Nagler; C Peters; A Velardi; M Mohty; A Madrigal
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

Review 7.  Multidisciplinary Management of Mycosis Fungoides/Sézary Syndrome.

Authors:  Sara Berg; Jennifer Villasenor-Park; Paul Haun; Ellen J Kim
Journal:  Curr Hematol Malig Rep       Date:  2017-06       Impact factor: 3.952

8.  Romidepsin enhances the cytotoxicity of fludarabine, clofarabine and busulfan combination in malignant T-cells.

Authors:  Benigno C Valdez; Jonathan E Brammer; Yang Li; David Murray; Esmeralda C Teo; Yan Liu; Chitra Hosing; Yago Nieto; Richard E Champlin; Borje S Andersson
Journal:  Leuk Res       Date:  2016-05-27       Impact factor: 3.156

Review 9.  Haploidentical stem cell transplantation for patients with lymphoma: a position statement from the Lymphoma Working Party-European Society for Blood and Marrow Transplantation.

Authors:  Sascha Dietrich; Peter Dreger; Olivier Hermine; Chara Kyriakou; Silvia Montoto; Steve Robinson; Norbert Schmitz; Harry C Schouten; Anna Sureda; Alina Tanase
Journal:  Bone Marrow Transplant       Date:  2019-05-31       Impact factor: 5.483

10.  Allogeneic stem-cell transplantation in patients with cutaneous lymphoma: updated results from a single institution.

Authors:  C Hosing; R Bassett; B Dabaja; R Talpur; A Alousi; S Ciurea; U Popat; M Qazilbash; E J Shpall; Y Oki; Y Nieto; C Pinnix; M Fanale; F Maadani; M Donato; R Champlin; M Duvic
Journal:  Ann Oncol       Date:  2015-09-28       Impact factor: 32.976
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.